Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831110 · ClinicalTrials.gov registry record
Aquagenic Wrinkling Prediction
A clinical trial of Carrier State and Aquagenic Wrinkling of Palms, sponsored by University of Iowa.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06831110 is a study of Carrier State and Aquagenic Wrinkling of Palms that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 2,000 participants, above the 537-participant average among 3 other Carrier State trials with a reported enrollment target (272% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06831110, a study of Carrier State and Aquagenic Wrinkling of Palms, is actively recruiting participants, sponsored by University of Iowa.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrinkling procedure to see how their hands respond.
Conditions Studied
Interventions
- PROCEDURE Aquagenic Wrinkling
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-03-06 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06831110
The ClinicalTrials.gov registry entry for NCT06831110 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 537-participant average among 3 other Carrier State trials with a reported enrollment target (272% higher). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Carrier State appearing as the primary indexed condition, and to 1 intervention - of which Aquagenic Wrinkling is the first listed.
NCT06831110 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06831110 about?
NCT06831110 is a clinical study titled "Aquagenic Wrinkling Prediction". The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrin...
What is the current status of trial NCT06831110?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-03-06. Estimated completion is 2026-12.
What conditions does trial NCT06831110 study?
This clinical trial studies the following conditions: Carrier State, Aquagenic Wrinkling of Palms.
What interventions are being tested in trial NCT06831110?
The interventions under investigation include: Aquagenic Wrinkling (PROCEDURE).
Who is sponsoring clinical trial NCT06831110?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831110 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carrier State
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.